Curcumin affects β-catenin pathway in hepatic stellate cell in vitro and in vivo

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 11, 2014, Pages 1615-1622

  Cui, Lei ^a   Jia, Xin ^b   Zhou, Qian ^b   Zhai, Xuguang ^b   Zhou, Yajun ^b   Zhu, Huixia ^b  

^a NANTONG UNIVERSITY   (China)

^b NANTONG MEDICAL COLLEGE   (China)

Author keywords

Curcumin; Delta like homologue 1; Hepatic stellate cell; Liver fibrosis; catenin

Indexed keywords

BETA CATENIN; CELL PROTEIN; CURCUMIN; DELTA LIKE HOMOLOG 1 PROTEIN; DNA; MESSENGER RNA; UNCLASSIFIED DRUG; DLK1 PROTEIN, RAT; MEMBRANE PROTEIN; PLANT EXTRACT; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL ACTIVITY; CELL ASSAY; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; DRUG DNA BINDING; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STELLATE CELL; WESTERN BLOTTING; ANIMAL; CHEMISTRY; CURCUMA; DRUG EFFECTS; LIVER CIRRHOSIS; METABOLISM; PHYTOTHERAPY; SPRAGUE DAWLEY RAT;

ANIMALS; BETA CATENIN; CURCUMA; CURCUMIN; HEPATIC STELLATE CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER CIRRHOSIS; MEMBRANE PROTEINS; PHYTOTHERAPY; PLANT EXTRACTS; RATS, SPRAGUE-DAWLEY;

EID: 84915784628     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12283     Document Type: Article

References (38)

1. MacDonald BT, Tamai K. Wnt/ beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9-26
2. Guo Y et al. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res 2012; 61: 337-346
3. Biernacka A et al. TGF-beta signaling in fibrosis. Growth Factors 2011; 29: 196-202
4. Hazra S et al. Peroxisome proliferatoractivated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 2004; 279: 11392-11401
5. Tsukamoto H. Adipogenic phenotype of hepatic stellate cells. Alcohol Clin Exp Res 2005; 29: 132S-133S
6. Qian J et al. β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells. Pharmacol Res 2012; 66: 219-225
7. Zhai X et al. The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis. Br J Pharmacol 2013; 169: 197-212
8. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011; 6: 425-456
9. Wells RG. Liver fibrosis: challenges of the new era. Gastroenterology 2009; 136: 387-388
10. O'Connell MA, Rushworth SA. Curcumin: potential for hepatic fibrosis therapy? Br J Pharmacol 2008; 153: 403-405
11. Aggarwal BB et al. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007; 595: 1-75
12. Fu Y et al. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 2008; 73: 399-409
13. Zheng S et al. De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell activation. Free Radic Biol Med 2007; 43: 444-453
14. Tang Y, Chen A. Curcumin protects hepatic stellate cells against leptininduced activation in vitro by accumulating intracellular lipids. Endocrinology 2010; 151: 4168-4177
15. Valenta T et al. The many faces and functions of β-catenin. EMBO J 2012; 31: 2714-2736
16. Zhou Y et al. Leptin inhibits PPARgamma gene expression in hepatic stellate cells in the mouse model of liver damage. Mol Cell Endocrinol 2010; 323: 193-200
17. Yan K et al. p38 MAPK and LXRα mediate leptin effect on SREBP-1c expression in hepatic stellate cells. Mol Med 2012; 18: 10-18
18. Honda H et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 2002; 36: 12-21
19. Zhou Y et al. PI-3 K/AKT and ERK signaling pathways mediate leptininduced inhibition of PPARgamma gene expression in primary rat hepatic stellate cells. Mol Cell Biochem 2009; 325: 131-139
20. Schmittgen TD et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 2000; 285: 194-204
21. Zhou Y et al. Egr-1 is involved in the inhibitory effect of leptin on PPARgamma expression in hepatic stellate cell in vitro. Life Sci 2009; 84: 544-551
22. Apte U et al. Beta-Catenin is critical for early postnatal liver growth. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1578-G1585
23. Zhou Y et al. The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro. Lab Invest 2007; 8: 488-498
24. Zhu NL et al. Hepatic stellate cellderived delta-like homolog 1 (DLK1) protein in liver regeneration. J Biol Chem 2012; 28: 10355-10367
25. Pan RL et al. Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation. J Biol Chem 2011; 286: 12340-12348
26. Qiu J et al. Curcumin regulates deltalike homolog 1 expression in activated hepatic stellate cell. Eur J Pharmacol 2014; 728: 9-15
27. Akhmetshina A et al. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun 2012; 3: 735-747
28. Arellanes-Robledo J et al. Fibrogenic actions of acetaldehyde are β-catenin dependent but Wingless independent: a critical role of nucleoredoxin and reactive oxygen species in human hepatic stellate cells. Free Radic Biol Med 2013; 65: 1487-1496
29. Lam AP, Gottardi CJ. β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol 2011; 23: 562-567
30. Gupta SC et al. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 2013; 39: 2-13
31. Yallapu MM et al. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res 2010; 3: 11-23
32. Shao W et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE 2012; 7: e28784
33. Sundram V et al. Curcumin attenuates b-catenin signaling in prostate cancer cells through activation of protein kinase D1. PLoS ONE 2012; 7: e35368
34. Zhang X et al. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells. Eur J Pharm Sci 2011; 42: 540-546
35. Arango NA et al. Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol 2005; 288: 276-283
36. Christodoulides C et al. Adipogenesis and WNT signalling. Trends Endocrinol Metab 2009; 20: 16-24
37. Cheng JH et al. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2008; 294: G39-G49
38. Sul HS. Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. Mol Endocrinol 2009; 23: 1717-1725